Catégorie : Documents

Catégories
Documents English-site

Documents, Rapports et Publications

Docs, reports and publications

  • Étiquettes
Catégories
Annonces Documents

Enquête annuelle « tuberculose MDR »

Le CNR continue la surveillance de la tuberculose multirésistante (résistance à l’isoniazide et la rifampicine, ou MDR) en France débutée en 1992.

La fiche d’enquête est dématérialisée

  1. ENQUETE 2022 – en cours (voir les questions sur le document PDF)
  2. Enquête 2021, reste ouverte pour les retardataires
  • Le numérateur est constitué du nombre de cas de tuberculose MDR.
  • Afin d’obtenir un dénominateur sur le nombre de tuberculose à culture positive en France, le CNR recueille le nombre de cas de tuberculose à culture positive identifié dans chaque laboratoire.
  • cette enquête permet également un bilan des tuberculoses mono-résistantes à la rifampicine et de la méningite tuberculeuse à culture positive

Les résultats sont disponibles dans les rapports annuels du CNR ou sur la page dédiée

L’historique des enquêtes est disponible sur l’ancien site du CNR

Catégories
Documents English-site Tout le CNR-MyRMA

Publications du CNR-MyRMA

Publications of the NRC

2023

Publications par thème ou par année

Classification annuelle – voir ci dessous (by date, see below)
2023

Publications 2023

Cliquer ici pour toutes les publications du CNR-MyRMA en 2023

“Clinical Implications of Molecular Drug Resistance Testing for Mycobacterium Tuberculosis: A 2023 TBnet/RESIST-TB Consensus Statement” by José Domínguez et al. The Lancet Infectious Diseases, February 28, 2023. https://doi.org/10.1016/S1473-3099(22)00875-1.

2022

Publications 2022

Cliquer ici pour toutes les publications du CNR-MyRMA en 2022 – extrait ci-dessous

“Lipophilic Quinolone Derivatives: Synthesis and in Vitro Antibacterial Evaluation” by Elodie Sadowski et al. Bioorganic & Medicinal Chemistry Letters. 55 (January 1, 2022). https://doi.org/10.1016/j.bmcl.2021.128450.

2021

Publications 2021

Cliquer ici pour toutes les publications du CNR-MyRMA en 2021

“A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium Tuberculosis Complex Directly From Clinical Samples” by Isabelle Bonnet et al. Frontiers in Cellular and Infection Microbiology. 11 (October 29, 2021). https://doi.org/10.3389/fcimb.2021.707244.

2020

Publications 2020

Cliquer ici pour toutes les publications du CNR-MyRMA en 2020

“Rifampicin and Clarithromycin (Extended Release) versus Rifampicin and Streptomycin for Limited Buruli Ulcer Lesions: A Randomised, Open-Label, Non-Inferiority Phase 3 Trial” by Richard O Phillips et al. The Lancet. 395, no. 10232 (April 18, 2020). https://doi.org/10.1016/S0140-6736(20)30047-7.

2019

Publications 2019

Cliquer ici pour toutes les publications du CNR-MyRMA en 2019

“Overall Structures of Mycobacterium Tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity” by Stéphanie Petrella et al. Structure. 27, no. 4 (avril 2019). https://doi.org/10.1016/j.str.2019.01.004.

2018

Publications 2018

Cliquer ici pour toutes les publications du CNR-MyRMA en 2018

“Antimicrobial Resistance in Leprosy: Results of the First Prospective Open Survey Conducted by a WHO Surveillance Network for the Period 2009–15” by E. Cambau et al. Clinical Microbiology and Infection. 24, no. 12 (December 1, 2018). https://doi.org/10.1016/j.cmi.2018.02.022.

2017

Publications 2017

Cliquer ici pour toutes les publications du CNR-MyRMA en 2017

“Are Moxifloxacin and Levofloxacin Equally Effective to Treat XDR Tuberculosis?” by Thomas Maitre et al. Journal of Antimicrobial Chemotherapy. 72, no. 8 (August 1, 2017). https://doi.org/10.1093/jac/dkx150.

2016

Publications 2016

Cliquer ici pour toutes les publications du CNR-MyRMA en 2016

“In Vivo Mycobacterium Tuberculosis Fluoroquinolone Resistance Emergence: A Complex Phenomenon Poorly Detected by Current Diagnostic Tests” by Christine Bernard et al. The Journal of Antimicrobial Chemotherapy, September 7, 2016. https://doi.org/10.1093/jac/dkw344.

2015

Publications 2015

Cliquer ici pour toutes les publications du CNR-MyRMA en 2015

“Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort” by Lorenzo Guglielmetti et al. Clinical Infectious Diseases. 60, no. 2 (January 15, 2015). https://doi.org/10.1093/cid/ciu786.

2014

Publications 2014

Cliquer ici pour toutes les publications du CNR-MyRMA en 2014

“Comparison of a Semiautomated Commercial Repetitive-Sequence-Based PCR Method with Spoligotyping, 24-Locus Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat Typing, and Restriction Fragment Length Polymorphism-Based Analysis of IS6110 for Mycobacterium Tuberculosis Typing” by F. Brossier et al. Journal of Clinical Microbiology. 52, no. 11 (November 1, 2014). https://doi.org/10.1128/JCM.02226-14.

2013

Publications 2013

Cliquer ici pour toutes les publications du CNR-MyRMA en 2013

“Resistance of M. Leprae to Quinolones: A Question of Relativity?” by Nicolas Veziris et al. PLoS Negl Trop Dis. 7, no. 11 (November 14, 2013). https://doi.org/10.1371/journal.pntd.0002559.

2012

Publications 2012

Cliquer ici pour toutes les publications du CNR-MyRMA en 2012 / click here

“Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium Tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. Tuberculosis” by Alix Pantel et al. Antimicrobial Agents and Chemotherapy. 56, no. 4 (April 2012). https://doi.org/10.1128/AAC.06272-11.

2011

Publications 2011

Cliquer ici pour toutes les publications du CNR-MyRMA en 2011 / click here

“Crystal Structure of the Pyrazinamidase of Mycobacterium Tuberculosis : Insights into Natural and Acquired Resistance to Pyrazinamide” by Stéphanie Petrella et al. PLOS ONE. 6, no. 1 (January 24, 2011). https://doi.org/10.1371/journal.pone.0015785.

2010

Publications 2010

Cliquer ici pour toutes les publications du CNR-MyRMA en 2010 / click here

“Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium Tuberculosis Complex Isolates” by Florence Brossier et al. Journal of Clinical Microbiology. 48, no. 5 (May 1, 2010). https://doi.org/10.1128/JCM.01947-09.

Catégories
Documents Tout le CNR-MyRMA

Publications – Mycobactéries atypiques

NTM – Non-tuberculous mycobacteria

Seules les publications les plus récentes sont présentées – Pour voir plus de publications aller à la page de recherche : toutes les publications
Only the most recent publications are displayed – to see more, go to the search page : all publications

Chiron, R., Hoefsloot, W., Van Ingen, J., Marchandin, H., Kremer, L., Morisse-Pradier, H., Charriot, J., Mallet, J.-P., Herrmann, J.-L., Caimmi, D., Moreau, J., Dumont, Y., Godreuil, S., Bergeron, A., Drevait, M., Bouzat-Rossigneux, E., Terrail, N., Andrejak, C., Veziris, N., Grenet, D., Coudrat, A. and Catherinot, E. (2022). Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience. Open Forum Infect Dis 9, ofac465, http://doi.org/10.1093/ofid/ofac465.
Chaptal, M., Andrejak, C., Bonifay, T., Beillard, E., Guillot, G., Guyomard-Rabenirina, S., Demar, M., Trombert-Paolantoni, S., Jacomo, V., Mosnier, E., Veziris, N., Djossou, F., Epelboin, L. and Group, F. G. P. working (2022). Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008–2018. PLOS Neglected Tropical Diseases 16, e0010693, http://doi.org/10.1371/journal.pntd.0010693.
Kilinç, G., Walburg, K. V., Franken, K. L. M. C., Valkenburg, M. L., Aubry, A., Haks, M. C., Saris, A. and Ottenhoff, T. H. M. (2022). Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium. Front Cell Infect Microbiol 12, 872361, http://doi.org/10.3389/fcimb.2022.872361.
Daniau, C., Lecorche, E., Mougari, F., Benmansour, H., Bernet, C., Blanchard, H., Robert, J., Berger-Carbonne, A. and Cambau, E. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020. Emerg Infect Dis 28, 518–526, http://doi.org/10.3201/eid2803.211791.
Lange, C., Böttger, E. C., Cambau, E., Griffith, D. E., Guglielmetti, L., van Ingen, J., Knight, S. L., Marras, T. K., Olivier, K. N., Santin, M., Stout, J. E., Tortoli, E., Wagner, D., Winthrop, K., Daley, C. L., Lange, C., Andrejak, C., Böttger, E., Cambau, E., Griffith, D., Guglielmetti, L., van Ingen, J., Knight, S., Leitman, P., Marras, T. K., Olivier, K. N., Santin, M., Stout, J. E., Tortoli, E., Wagner, D., Wallace, R. J., Winthrop, K. and Daley, C. (2022). Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. The Lancet Infectious Diseases, http://doi.org/10.1016/S1473-3099(21)00586-7.
Vongthilath-Moeung, R., Plojoux, J., Poncet, A., Renzi, G., Veziris, N., Schrenzel, J. and Janssens, J.-P. (2022). Nontuberculous Mycobacteria under Scrutiny in the Geneva Area (2015–2020). RES 101, 367–375, http://doi.org/10.1159/000520033.
Bemer, P., Peuchant, O., Guet-Revillet, H., Bador, J., Balavoine, C., Basille, D., Beltramo, G., Blanc, F.-X., Blanchard, E., Boulanger, S., Bourgoin, A., Boutoille, D., Cambau, E., Canis, F., Caparros, D., Carricajo, A., Carrière, C., Couetdic, G., Couturaud, F., Dalphin, J.-C., Degot, T., Desquiens, M., Devouassoux, G., Duez, J.-M., Dumitrescu, O., Dupuy-Grasset, M., Gaudart, A., Georges, M., Godet, C., Godreuil, S., Guillouzouic, A., Hamdad-Daoudi, F., Héry-Arnaud, G., Koebel, C., Lagrange, A., Lanotte, P., Marchand-Adam, S., Mougari, F., Murris, M., Patry, I., Pérouse de Montclos, M., Raskine, L., Risso, K., Segonds, C., Sicard, D., Terru, D., Vachée, A., Vergnon, J.-M., Martin, C., Schramm, F. and Andrejak, C. (2021). Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study. BMC Pulm Med 21, 1–9, http://doi.org/10.1186/s12890-021-01701-5.
Veziris, N., Andréjak, C., Bouée, S., Emery, C., Obradovic, M. and Chiron, R. (2021). Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study. BMC Infect Dis 21, 1–10, http://doi.org/10.1186/s12879-021-06825-x.
Lecorche, E., Daniau, C., La, K., Mougari, F., Benmansour, H., Kumanski, S., Robert, J., Fournier, S., Lebreton, G., Carbonne, A., Cambau, E. and CNR-MyRMA (2021). Mycobacterium chimaera Genomics With Regard to Epidemiological and Clinical Investigations Conducted for an Open Chest Postsurgical Mycobacterium chimaera Infection Outbreak. Open Forum Infectious Diseases 8, ofab192, http://doi.org/10.1093/ofid/ofab192.
Opota, O., Mazza-Stalder, J., Viveiros, M., Cambau, E., Santin, M. and Goletti, D. (2021). Editorial: Tuberculosis and Non-tuberculous Mycobacteria Infections: Control, Diagnosis and Treatment. Frontiers in Public Health 9, URL: https://www.frontiersin.org/article/10.3389/fpubh.2021.666187 [Accessed March 2022].
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Jr, Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., Huitt, G. A., Knight, S. L., Leitman, P., Marras, T. K., Olivier, K. N., Santin, M., Stout, J. E., Tortoli, E., van Ingen, J., Wagner, D. and Winthrop, K. L. (2020). Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clinical Infectious Diseases 71, e1–e36, http://doi.org/10.1093/cid/ciaa241.
Marsollier, L., Aubry, A., Carbonnelle, E., Canaan, S., Laencina, L., Cambau, E. and Herrmann, J. (2020). Mycobactérioses cutanées dues à Mycobacterium ulcerans, Mycobacterium marinum, Mycobacterium abscessus, Mycobacterium chelonae et autres mycobactéries non tuberculeuses. EM-Consulte, http://doi.org/10.1016/S1166-8598(19)81974-9.
Jaffré, J., Aubry, A., Maitre, T., Morel, F., Brossier, F., Robert, J., Sougakoff, W., Veziris, N. and the CNR-MyRMA (Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux) (2020). Rational Choice of Antibiotics and Media for Mycobacterium avium Complex Drug Susceptibility Testing. Frontiers in Microbiology 11, URL: https://www.frontiersin.org/article/10.3389/fmicb.2020.00081 [Accessed March 2022].
Lecorche, E., Pean de Ponfilly, G., Mougari, F., Benmansour, H., Poisnel, E., Janvier, F. and Cambau, E. (2020). Disseminated Mycobacterium chimaera Following Open-Heart Surgery, the Heater–Cooler Unit Worldwide Outbreak: Case Report and Minireview. Frontiers in Medicine 7, URL: https://www.frontiersin.org/article/10.3389/fmed.2020.00243 [Accessed March 2022].
Daniau, C., Lecorché, E., Mougari, F. and et al. (2019). Infections invasives à Mycobacterium chimaera en chirurgie cardiaque et évaluation des pratiques autour des matériels de circulation extracorporelle. Hygienes 27, 351–359, http://doi.org/10.25329/hy_xxvii_6-1.
Rollet-Cohen, V., Roux, A.-L., Bourgeois, M. L., Sapriel, G., Bahri, M. E., Jais, J.-P., Heym, B., Mougari, F., Raskine, L., Véziris, N., Gaillard, J.-L. and Sermet-Gaudelus, I. (2019). Mycobacterium bolletii lung disease in cystic fibrosis. CHEST 0, http://doi.org/10.1016/j.chest.2019.03.019.
Dutertre, M., Delobel, P., Marchou, B., Boyer, J.-F., Mougari, F. and Martin-Blondel, G. (2019). Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritis. Médecine et Maladies Infectieuses 49, 358–359, http://doi.org/10.1016/j.medmal.2019.03.002.
Decalonne, M., Lecorche, E., Hau, E., Petiteau, A., Moreau, C., Milan, O., Lanotte, P., Mereghetti, L., Cambau, E. and van der Mee-Marquet, N. (2019). Cause Analysis of an Infection in Facelift Surgery Due to Mycobacterium chelonae. Frontiers in Medicine 6, URL: https://www.frontiersin.org/article/10.3389/fmed.2019.00243 [Accessed February 2022].
Griffith, D. E., Eagle, G., Thomson, R., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O’Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J.-J., Ringshausen, F. C., Field, S. K., Philley, J. V., Wallace, R. J., van Ingen, J., Coulter, C., Nezamis, J. and Winthrop, K. L. (2018). Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med 198, 1559–1569, http://doi.org/10.1164/rccm.201807-1318OC.
Coolen-Allou, N., Touron, T., Belmonte, O., Gazaille, V., Andre, M., Allyn, J., Picot, S., Payet, A. and Veziris, N. (2018). Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients. Antimicrobial Agents and Chemotherapy 62, e00395-18, http://doi.org/10.1128/AAC.00395-18.
Lecorche, E., Haenn, S., Mougari, F., Kumanski, S., Veziris, N., Benmansour, H., Raskine, L., Moulin, L., Cambau, E., Aubry, A., Brossier, F., Chauffour, A., Jaffre, J., Jarlier, V., Robert, J. and Sougakoff, W. (2018). Comparison of methods available for identification of Mycobacterium chimaera. Clinical Microbiology and Infection 24, 409–413, http://doi.org/10.1016/j.cmi.2017.07.031.
van Ingen, J., Aksamit, T., Andrejak, C., Böttger, E. C., Cambau, E., Daley, C. L., Griffith, D. E., Guglielmetti, L., Holland, S. M., Huitt, G. A., Koh, W.-J., Lange, C., Leitman, P., Marras, T. K., Morimoto, K., Olivier, K. N., Santin, M., Stout, J. E., Thomson, R., Tortoli, E., Wallace, R. J., Winthrop, K. L. and Wagner, D. (2018). Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. European Respiratory Journal 51, 1800170, http://doi.org/10.1183/13993003.00170-2018.
Bouchet, F., Martin, B., Aubry, A., Veziris, N., Lavigne, J.-P. and Sotto, A. (2017). Should single antibiotic therapy be avoided for nontuberculous mycobacteria? Médecine et Maladies Infectieuses, http://doi.org/10.1016/j.medmal.2017.07.004.
Leyer, C., Gregorowicz, G., Mougari, F., Raskine, L., Cambau, E. and Briel, D. de (2017). Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media. Journal of Clinical Microbiology 55, 2045–2054, http://doi.org/10.1128/JCM.00006-17.
Mougari, F., Loiseau, J., Veziris, N., Bernard, C., Bercot, B., Sougakoff, W., Jarlier, V., Raskine, L. and Cambau, E. (2017). Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. J Antimicrob Chemother 72, 1669–1677, http://doi.org/10.1093/jac/dkx021.
Delafont, V., Samba-Louaka, A., Cambau, E., Bouchon, D., Moulin, L. and Héchard, Y. (2017). Mycobacterium llatzerense, a waterborne Mycobacterium, that resists phagocytosis by Acanthamoeba castellanii. Scientific Reports 7, 46270, http://doi.org/10.1038/srep46270.
Aubry, A., Mougari, F., Reibel, F. and Cambau, E. (2017). Mycobacterium marinum. Microbiology Spectrum 5, http://doi.org/10.1128/microbiolspec.TNMI7-0038-2016.
Mougari, F., Bouziane, F., Crockett, F., Nessar, R., Chau, F., Veziris, N., Sapriel, G., Raskine, L. and Cambau, E. (2017). Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. Antimicrob Agents Chemother 61, e00943-16, http://doi.org/10.1128/AAC.00943-16.
Mougari, F., Guglielmetti, L., Raskine, L., Sermet-Gaudelus, I., Veziris, N. and Cambau, E. (2016). Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Review of Anti-infective Therapy 14, 1139–1154, http://doi.org/10.1080/14787210.2016.1238304.
Mougari, F., Amarsy, R., Veziris, N., Bastian, S., Brossier, F., Berçot, B., Raskine, L. and Cambau, E. (2016). Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar. J Antimicrob Chemother 71, 2208–2212, http://doi.org/10.1093/jac/dkw130.
Parize, P., Hamelin, A., Veziris, N., Morand, P. C., Guillemain, R., Lortholary, O. and Dupin, N. (2016). Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. Journal of the European Academy of Dermatology and Venereology 30, 101–105, http://doi.org/10.1111/jdv.12965.
Chazel, M., Marchandin, H., Keck, N., Terru, D., Carrière, C., Ponsoda, M., Jacomo, V., Panteix, G., Bouzinbi, N., Bañuls, A.-L., Choisy, M., Solassol, J., Aubry, A. and Godreuil, S. (2016). Evaluation of the SLOMYCO Sensititre® panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates. Annals of Clinical Microbiology and Antimicrobials 15, 30, http://doi.org/10.1186/s12941-016-0145-1.
Renvoisé, A., Brossier, F., Galati, E., Veziris, N., Sougakoff, W., Aubry, A., Robert, J., Cambau, E., Jarlier, V. and Bernard, C. (2015). Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex. Antimicrobial Agents and Chemotherapy 59, 7153–7155, http://doi.org/10.1128/AAC.01027-15.
Guglielmetti, L., Mougari, F., Lopes, A., Raskine, L. and Cambau, E. (2015). Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists’ point of view. Future Microbiology 10, 1467–1483, http://doi.org/10.2217/fmb.15.64.
Coolen, N., Morand, P., Martin, C., Hubert, D., Kanaan, R., Chapron, J., Honoré, I., Dusser, D., Audureau, E., Veziris, N. and Burgel, P.-R. (2015). Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. Journal of Cystic Fibrosis 14, 594–599, http://doi.org/10.1016/j.jcf.2015.02.006.
Roux, A.-L., Catherinot, E., Soismier, N., Heym, B., Bellis, G., Lemonnier, L., Chiron, R., Fauroux, B., Le Bourgeois, M., Munck, A., Pin, I., Sermet, I., Gutierrez, C., Veziris, N., Jarlier, V., Cambau, E., Herrmann, J.-L., Guillemot, D. and Gaillard, J.-L. (2015). Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis 14, 63–69, http://doi.org/10.1016/j.jcf.2014.07.004.
Renvoise, A., Bernard, C., Veziris, N., Galati, E., Jarlier, V. and Robert, J. (2014). Significant Difference in Drug Susceptibility Distribution between Mycobacterium avium and Mycobacterium intracellulare. Journal of Clinical Microbiology 52, 4439–4440, http://doi.org/10.1128/JCM.02127-14.
Renvoise, A. and Bernard, C. (2014). Traitement des infections à Mycobacterium avium complex. J Antiinf 16, 199–206, http://doi.org/10.1016/j.antinf.2014.10.003.
Delafont, V., Mougaris, F., Cambau, E., Joyeux, michel, Bouchon, D., Hechard, Y. and Moulin, L. (2014). First evidence of amoebae – mycobacteria association in drinking water network. Environ Sci Technol, http://doi.org/10.1021/es5036255.
Fangous, M.-S., Mougari, F., Gouriou, S., Calvez, E., Raskine, L., Cambau, E., Payan, C. and Héry-Arnaud, G. (2014). Classification Algorithm for Subspecies Identification within the Mycobacterium abscessus Species, Based on Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry. J Clin Microbiol 52, 3362–3369, http://doi.org/10.1128/JCM.00788-14.
Mougari, F., Raskine, L., Ferroni, A., Marcon, E., Sermet-Gaudelus, I., Veziris, N., Heym, B., Gaillard, J.-L., Nassif, X. and Cambau, E. (2014). Clonal Relationship and Differentiation among Mycobacterium abscessus Isolates as Determined Using the Semiautomated Repetitive Extragenic Palindromic Sequence PCR-Based DiversiLab System. J Clin Microbiol 52, 1969–1977, http://doi.org/10.1128/JCM.03600-13.
Lerat, I., Cambau, E., Bettoni, R. R. dit, Gaillard, J.-L., Jarlier, V., Truffot, C. and Veziris, N. (2014). In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus. J Infect Dis 209, 905–912, http://doi.org/10.1093/infdis/jit614.
Macheras, E., Konjek, J., Roux, A.-L., Thiberge, J.-M., Bastian, S., Leão, S. C., Palaci, M., Sivadon-Tardy, V., Gutierrez, C., Richter, E., Rüsch-Gerdes, S., Pfyffer, G. E., Bodmer, T., Jarlier, V., Cambau, E., Brisse, S., Caro, V., Rastogi, N., Gaillard, J.-L. and Heym, B. (2014). Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Research in Microbiology, http://doi.org/10.1016/j.resmic.2013.12.003.
Radomski, N., Roguet, A., Lucas, F. S., Veyrier, F. J., Cambau, E., Accrombessi, H., Moilleron, R., Behr, M. A. and Moulin, L. (2013). atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples. BMC Microbiology 13, 277, http://doi.org/10.1186/1471-2180-13-277.
Veziris, N., Chauffour, A., Escolano, S., Henquet, S., Matsuoka, M., Jarlier, V. and Aubry, A. (2013). Resistance of M. leprae to Quinolones: A Question of Relativity? PLoS Negl Trop Dis 7, e2559, http://doi.org/10.1371/journal.pntd.0002559.
Pang, S., Renvoisé, A., Perret, C., Guinier, M., Chelghoum, N., Brossier, F., Capton, E., Jarlier, V. and Sougakoff, W. (2013). Whole-Genome Sequence of Mycobacterium abscessus Clinical Strain V06705. Genome Announc 1, e00690-13, http://doi.org/10.1128/genomeA.00690-13.
Gomez, C., Ponien, P., Serradji, N., Lamouri, A., Pantel, A., Capton, E., Jarlier, V., Anquetin, G. and Aubry, A. (2013). Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry 21, 948–956, http://doi.org/10.1016/j.bmc.2012.12.011.
Grammatico-Guillon, L., Lanotte, P., Bastides, F., Veziris, N., Bernard, L. and Rosset, P. (2013). Voluminous pseudotumor due to Mycobacterium malmoense. Presse Med 42, 227–230, http://doi.org/10.1016/j.lpm.2012.02.042.
Mechaï, F., Veziris, N., Aoun, O., Bille, E., Lecuit, M., Brossier, F., Viard, J. P. and Lortholary, O. (2013). In vivo selection of a multidrug-resistant Mycobacterium avium isolate in a patient with AIDS. Int J Tuberc Lung Dis 17, 141–142, http://doi.org/10.5588/ijtld.12.0778.
Mougari, F., Guglielmetti, L., Lopes, A., Raskine, L. and Cambau, E. (2013). Mycobactérioses non tuberculeuses hors mycobactérioses cutanées. In: Revue Encyclopédie Médico Chirurgicale,.
Lhuillier, E., Brugière, O., Veziris, N., Danel, C., Mourvilliers, B., Mal, H., Dauriat, G. and Ruimy, R. (2012). Relapsing Mycobacterium genavense infection as a cause of late death in a lung transplant recipient: case report and review of the literature. Exp Clin Transplant 10, 618–620, http://doi.org/10.6002/ect.2012.0052.
Dutilh, J., Caron, F., Bourgoin, A., Veziris, N. and Meurice, J.-C. (2012). Un cas atypique de mycobactérie. Revue des Maladies Respiratoires 29, 1182, http://doi.org/10.1016/j.rmr.2012.10.014.
Cosson, M.-A., Bertrand, J.-B., Martin, C., Veziris, N., Picard, C., Goulvestre, C., Coignard, S., Benoit, J.-P., Silvera, S., Moro, M.-R., Poyart, C. and Morand, P. C. (2012). Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient. J Med Microbiol 61, 1617–1620, http://doi.org/10.1099/jmm.0.042739-0.
Legout, L., Ettahar, N., Massongo, M., Veziris, N., Ajana, F., Beltrand, E. and Senneville, E. (2012). Osteomyelitis of the wrist caused by Mycobacterium arupense in an immunocompetent patient: a unique case. Int J Infect Dis 16, e761-762, http://doi.org/10.1016/j.ijid.2012.05.007.
Cambau, E., Chauffour-Nevejans, A., Tejmar-Kolar, L., Matsuoka, M. and Jarlier, V. (2012). Detection of Antibiotic Resistance in Leprosy Using GenoType LepraeDR, a Novel Ready-To-Use Molecular Test. PLoS Negl Trop Dis 6, e1739, http://doi.org/10.1371/journal.pntd.0001739.
Nessar, R., Cambau, E., Reyrat, J. M., Murray, A. and Gicquel, B. (2012). Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 67, 810–818, http://doi.org/10.1093/jac/dkr578.
Andréjak, C., Veziris, N., Lescure, X., Cadranel, J. and Jounieaux, V. (2012). Essai CaMoMy : évaluation de la capacité de deux schémas thérapeutiques (Clarithromycine ou Moxifloxacine) à négativer les cultures à six mois de malades porteurs d’une infection pulmonaire à Mycobacterium xenopi. PHRC national 2010. Revue des Maladies Respiratoires 29, Supplement 1, A25, http://doi.org/10.1016/j.rmr.2011.10.030.
Bussone, G., Brossier, F., Roudiere, L., Bille, E., Sekkal, N., Charlier, C., Gilquin, J., Lanternier, F., Lecuit, M., Lortholary, O. and Catherinot, E. (2012). Recurrent Mycobacterium avium infection after seven years of latency in a HIV-infected patient receiving efficient antiretroviral therapy. Journal of Infection 64, 613–617, http://doi.org/10.1016/j.jinf.2011.12.020.
Prevotat, A., Bonne, S., Veziris, N., Senneville, E., Yazdanpanah, Y. and Legout, L. (2011). [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Med Mal Infect 41, 446–448, http://doi.org/10.1016/j.medmal.2011.02.011.
Radomski, N., Betelli, L., Moilleron, R., Haenn, S., Moulin, L., Cambau, E., Rocher, V., Gonçalves, A. and Lucas, F. S. (2011). Mycobacterium Behavior in Wastewater Treatment Plant, A Bacterial Model Distinct From Escherichia coli and Enterococci. Environ Sci Technol 45, 5380–5386, http://doi.org/10.1021/es104084c.
Macheras, E., Roux, A.-L., Bastian, S., Leão, S. C., Palaci, M., Sivadon-Tardy, V., Gutierrez, C., Richter, E., Rüsch-Gerdes, S., Pfyffer, G., Bodmer, T., Cambau, E., Gaillard, J.-L. and Heym, B. (2011). Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains. J Clin Microbiol 49, 491–499, http://doi.org/10.1128/JCM.01274-10.
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V. and Cambau, E. (2011). Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing. Antimicrob Agents Chemother 55, 775–781, http://doi.org/10.1128/AAC.00861-10.
Cribier, B., Aubry, A., Caumes, E., Cambau, E., Jarlier, V. and Chosidow, O. (2011). [Histopathological study of Mycobacterium marinum infection]. Ann Dermatol Venereol 138, 17–22, http://doi.org/10.1016/j.annder.2010.10.025.
Ali, M. A., Bastian, S., Ismail, R., Choon, T. S., Ali, S., Aubry, A., Pandian, S., Saraswat, P., Singh, A. and Gaur, R. (2011). Discovery of novel methanone derivatives acting as antimycobacterial agents. Journal of Enzyme Inhibition and Medicinal Chemistry 26, 890–894, http://doi.org/10.3109/14756366.2011.559945.
Couderc, C., Carbonne, A., Thiolet, J. M., Brossier, F., Savey, A., Bernet, C., Ortmans, C., Lecadet-Morin, C., Coudière, I., Aggoune, M., Astagneau, P., Coignard, B. and Cambau, E. (2011). Infections à mycobactéries atypiques liées à des soins esthétiques en France, 2001–2010. Médecine et Maladies Infectieuses 41, 379–383, http://doi.org/10.1016/j.medmal.2011.02.007.
Lerat, I., Truffot, C. and Veziris, N. (2011). Infections à Mycobacterium abscessus : épidémiologie, aspects cliniques et traitement. Journal des Anti-infectieux 13, 49–55.
Radomski, N., Cambau, E., Moulin, L., Haenn, S., Moilleron, R. and Lucas, F. S. (2010). Comparison of Culture Methods for Isolation of Nontuberculous Mycobacteria from Surface Waters. Appl Environ Microbiol 76, 3514–3520, http://doi.org/10.1128/AEM.02659-09.
Bastian, S., Brossier, F., Wichlacz, C., Jarlier, V. and Veziris, N. (2010). Daptomycin is not active against rapidly growing mycobacteria. J Med Microbiol 59, 135–136, http://doi.org/10.1099/jmm.0.014274-0.
Marsollier, L., Aubry, A., Carbonnelle, E., Canaan, S., Cambau, E. and Herrmann, J.-L. (2010). Les Mycobactérioses cutanées dues à Mycobacterium ulcerans, Mycobacterium marinum, Mycobacterium abscessus, Mycobacterium chelonae et autres mycobactéries non tuberculeuses, L’Encyclopédie Médico-chirurgicale.
Cambau, E. and Aubry, A. (2010). Mycobacterium marinum. In: Tuberculosis, McGraw-Hill Professional Medical Publishing Division.
Carbonne, A., Brossier, F., Arnaud, I., Bougmiza, I., Caumes, E., Meningaud, J.-P., Dubrou, S., Jarlier, V., Cambau, E. and Astagneau, P. (2009). Outbreak of Nontuberculous Mycobacterial Subcutaneous Infections Related to Multiple Mesotherapy Injections. J Clin Microbiol 47, 1961–1964, http://doi.org/10.1128/JCM.00196-09.
Veziris, N., Aubry, A., Robert, J., Cambau, E., Jarlier, V. and Truffot-Pernot, C. (2009). Mycobacteria. In: Antibiogram, Eska and ASM editors.
Régnier, S., Martinez, V., Veziris, N., Bonvallot, T., Meningaud, J.-P. and Caumes, E. (2008). [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases]. Ann Dermatol Venereol 135, 591–595, http://doi.org/10.1016/j.annder.2008.03.029.